Composition and method for the treatment of neurological diseases and cerebral injury
US-2015359762-A1 · Dec 17, 2015 · US
Compositions and methods for treating and preventing skeletal muscle deficiencies
US9107940B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9107940-B2 |
| Application number | US-201414508599-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 7, 2014 |
| Priority date | Dec 17, 2007 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a contraction force deficit; skeletal muscle having a Ca 2+ imbalance; skeletal muscle having microtears).
First claim
Opening claim text (preview).
We claim: 1. A method of treating or reducing diaphragm skeletal muscle injury or diaphragm skeletal muscle deficiency in a subject comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of a poloxamer. 2. A methhod of claim 1 , wherein said diaphragm skeletal muscle deficiency is a skeletal muscle contraction force deficit. 3. A method of claim 1 , wherein said poloxamer is a purif…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/765Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9107940B2 cover?
- The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a con…
- Who is the assignee on this patent?
- Univ Michigan, Phrixus Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/765. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).